Global Type-1 Diabetes Treatment Market Growth (Status and Outlook) 2025-2031

September 2025 | 114 pages | ID: G9F006529EA5EN
LP Information

Abstracts

According to this study, the global Type-1 Diabetes Treatment market size will reach US$ 7522 million by 2031.

Type-1 diabetes accounts for 5%–10% of all diabetes cases worldwide. Failure to produce insulin is the cause of this type of diabetes.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Type-1 Diabetes Treatment Industry Forecast” looks at past sales and reviews total world Type-1 Diabetes Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Type-1 Diabetes Treatment sales for 2025 through 2031. With Type-1 Diabetes Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Type-1 Diabetes Treatment industry.

This Insight Report provides a comprehensive analysis of the global Type-1 Diabetes Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Type-1 Diabetes Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Type-1 Diabetes Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Type-1 Diabetes Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Type-1 Diabetes Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Type-1 Diabetes Treatment market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Rapid-Acting Insulin
• Short-Acting Insulin
• Others

Segmentation by Application:

• Hospitals & Clinics
• Academic & Research Institutes

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Astellas Pharma
• Merck
• Eli Lilly
• Novo Nordisk
• Sanofi
• AstraZeneca
• Boehringer Ingelheim GmbH
• Novartis
• Pfizer Inc.
• Abbott Laboratories
• Mannkind Corporation
• Braun Melsungen AG
• Macrogenics, Inc.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Type-1 Diabetes Treatment Market Size (2020-2031)
  2.1.2 Type-1 Diabetes Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Type-1 Diabetes Treatment by Country/Region (2020, 2024 & 2031)
2.2 Type-1 Diabetes Treatment Segment by Type
  2.2.1 Rapid-Acting Insulin
  2.2.2 Short-Acting Insulin
  2.2.3 Others
2.3 Type-1 Diabetes Treatment Market Size by Type
  2.3.1 Type-1 Diabetes Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Type-1 Diabetes Treatment Market Size Market Share by Type (2020-2025)
2.4 Type-1 Diabetes Treatment Segment by Application
  2.4.1 Hospitals & Clinics
  2.4.2 Academic & Research Institutes
2.5 Type-1 Diabetes Treatment Market Size by Application
  2.5.1 Type-1 Diabetes Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Type-1 Diabetes Treatment Market Size Market Share by Application (2020-2025)

3 TYPE-1 DIABETES TREATMENT MARKET SIZE BY PLAYER

3.1 Type-1 Diabetes Treatment Market Size Market Share by Player
  3.1.1 Global Type-1 Diabetes Treatment Revenue by Player (2020-2025)
  3.1.2 Global Type-1 Diabetes Treatment Revenue Market Share by Player (2020-2025)
3.2 Global Type-1 Diabetes Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 TYPE-1 DIABETES TREATMENT BY REGION

4.1 Type-1 Diabetes Treatment Market Size by Region (2020-2025)
4.2 Global Type-1 Diabetes Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Type-1 Diabetes Treatment Market Size Growth (2020-2025)
4.4 APAC Type-1 Diabetes Treatment Market Size Growth (2020-2025)
4.5 Europe Type-1 Diabetes Treatment Market Size Growth (2020-2025)
4.6 Middle East & Africa Type-1 Diabetes Treatment Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Type-1 Diabetes Treatment Market Size by Country (2020-2025)
5.2 Americas Type-1 Diabetes Treatment Market Size by Type (2020-2025)
5.3 Americas Type-1 Diabetes Treatment Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Type-1 Diabetes Treatment Market Size by Region (2020-2025)
6.2 APAC Type-1 Diabetes Treatment Market Size by Type (2020-2025)
6.3 APAC Type-1 Diabetes Treatment Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Type-1 Diabetes Treatment Market Size by Country (2020-2025)
7.2 Europe Type-1 Diabetes Treatment Market Size by Type (2020-2025)
7.3 Europe Type-1 Diabetes Treatment Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Type-1 Diabetes Treatment by Region (2020-2025)
8.2 Middle East & Africa Type-1 Diabetes Treatment Market Size by Type (2020-2025)
8.3 Middle East & Africa Type-1 Diabetes Treatment Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL TYPE-1 DIABETES TREATMENT MARKET FORECAST

10.1 Global Type-1 Diabetes Treatment Forecast by Region (2026-2031)
  10.1.1 Global Type-1 Diabetes Treatment Forecast by Region (2026-2031)
  10.1.2 Americas Type-1 Diabetes Treatment Forecast
  10.1.3 APAC Type-1 Diabetes Treatment Forecast
  10.1.4 Europe Type-1 Diabetes Treatment Forecast
  10.1.5 Middle East & Africa Type-1 Diabetes Treatment Forecast
10.2 Americas Type-1 Diabetes Treatment Forecast by Country (2026-2031)
  10.2.1 United States Market Type-1 Diabetes Treatment Forecast
  10.2.2 Canada Market Type-1 Diabetes Treatment Forecast
  10.2.3 Mexico Market Type-1 Diabetes Treatment Forecast
  10.2.4 Brazil Market Type-1 Diabetes Treatment Forecast
10.3 APAC Type-1 Diabetes Treatment Forecast by Region (2026-2031)
  10.3.1 China Type-1 Diabetes Treatment Market Forecast
  10.3.2 Japan Market Type-1 Diabetes Treatment Forecast
  10.3.3 Korea Market Type-1 Diabetes Treatment Forecast
  10.3.4 Southeast Asia Market Type-1 Diabetes Treatment Forecast
  10.3.5 India Market Type-1 Diabetes Treatment Forecast
  10.3.6 Australia Market Type-1 Diabetes Treatment Forecast
10.4 Europe Type-1 Diabetes Treatment Forecast by Country (2026-2031)
  10.4.1 Germany Market Type-1 Diabetes Treatment Forecast
  10.4.2 France Market Type-1 Diabetes Treatment Forecast
  10.4.3 UK Market Type-1 Diabetes Treatment Forecast
  10.4.4 Italy Market Type-1 Diabetes Treatment Forecast
  10.4.5 Russia Market Type-1 Diabetes Treatment Forecast
10.5 Middle East & Africa Type-1 Diabetes Treatment Forecast by Region (2026-2031)
  10.5.1 Egypt Market Type-1 Diabetes Treatment Forecast
  10.5.2 South Africa Market Type-1 Diabetes Treatment Forecast
  10.5.3 Israel Market Type-1 Diabetes Treatment Forecast
  10.5.4 Turkey Market Type-1 Diabetes Treatment Forecast
10.6 Global Type-1 Diabetes Treatment Forecast by Type (2026-2031)
10.7 Global Type-1 Diabetes Treatment Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Type-1 Diabetes Treatment Forecast

11 KEY PLAYERS ANALYSIS

11.1 Astellas Pharma
  11.1.1 Astellas Pharma Company Information
  11.1.2 Astellas Pharma Type-1 Diabetes Treatment Product Offered
  11.1.3 Astellas Pharma Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Astellas Pharma Main Business Overview
  11.1.5 Astellas Pharma Latest Developments
11.2 Merck
  11.2.1 Merck Company Information
  11.2.2 Merck Type-1 Diabetes Treatment Product Offered
  11.2.3 Merck Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Merck Main Business Overview
  11.2.5 Merck Latest Developments
11.3 Eli Lilly
  11.3.1 Eli Lilly Company Information
  11.3.2 Eli Lilly Type-1 Diabetes Treatment Product Offered
  11.3.3 Eli Lilly Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Eli Lilly Main Business Overview
  11.3.5 Eli Lilly Latest Developments
11.4 Novo Nordisk
  11.4.1 Novo Nordisk Company Information
  11.4.2 Novo Nordisk Type-1 Diabetes Treatment Product Offered
  11.4.3 Novo Nordisk Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Novo Nordisk Main Business Overview
  11.4.5 Novo Nordisk Latest Developments
11.5 Sanofi
  11.5.1 Sanofi Company Information
  11.5.2 Sanofi Type-1 Diabetes Treatment Product Offered
  11.5.3 Sanofi Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Sanofi Main Business Overview
  11.5.5 Sanofi Latest Developments
11.6 AstraZeneca
  11.6.1 AstraZeneca Company Information
  11.6.2 AstraZeneca Type-1 Diabetes Treatment Product Offered
  11.6.3 AstraZeneca Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 AstraZeneca Main Business Overview
  11.6.5 AstraZeneca Latest Developments
11.7 Boehringer Ingelheim GmbH
  11.7.1 Boehringer Ingelheim GmbH Company Information
  11.7.2 Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Product Offered
  11.7.3 Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Boehringer Ingelheim GmbH Main Business Overview
  11.7.5 Boehringer Ingelheim GmbH Latest Developments
11.8 Novartis
  11.8.1 Novartis Company Information
  11.8.2 Novartis Type-1 Diabetes Treatment Product Offered
  11.8.3 Novartis Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Novartis Main Business Overview
  11.8.5 Novartis Latest Developments
11.9 Pfizer Inc.
  11.9.1 Pfizer Inc. Company Information
  11.9.2 Pfizer Inc. Type-1 Diabetes Treatment Product Offered
  11.9.3 Pfizer Inc. Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Pfizer Inc. Main Business Overview
  11.9.5 Pfizer Inc. Latest Developments
11.10 Abbott Laboratories
  11.10.1 Abbott Laboratories Company Information
  11.10.2 Abbott Laboratories Type-1 Diabetes Treatment Product Offered
  11.10.3 Abbott Laboratories Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Abbott Laboratories Main Business Overview
  11.10.5 Abbott Laboratories Latest Developments
11.11 Mannkind Corporation
  11.11.1 Mannkind Corporation Company Information
  11.11.2 Mannkind Corporation Type-1 Diabetes Treatment Product Offered
  11.11.3 Mannkind Corporation Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Mannkind Corporation Main Business Overview
  11.11.5 Mannkind Corporation Latest Developments
11.12 Braun Melsungen AG
  11.12.1 Braun Melsungen AG Company Information
  11.12.2 Braun Melsungen AG Type-1 Diabetes Treatment Product Offered
  11.12.3 Braun Melsungen AG Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 Braun Melsungen AG Main Business Overview
  11.12.5 Braun Melsungen AG Latest Developments
11.13 Macrogenics, Inc.
  11.13.1 Macrogenics, Inc. Company Information
  11.13.2 Macrogenics, Inc. Type-1 Diabetes Treatment Product Offered
  11.13.3 Macrogenics, Inc. Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.13.4 Macrogenics, Inc. Main Business Overview
  11.13.5 Macrogenics, Inc. Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Type-1 Diabetes Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Type-1 Diabetes Treatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Rapid-Acting Insulin
Table 4. Major Players of Short-Acting Insulin
Table 5. Major Players of Others
Table 6. Type-1 Diabetes Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Type-1 Diabetes Treatment Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Type-1 Diabetes Treatment Market Size Market Share by Type (2020-2025)
Table 9. Type-1 Diabetes Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Type-1 Diabetes Treatment Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Type-1 Diabetes Treatment Market Size Market Share by Application (2020-2025)
Table 12. Global Type-1 Diabetes Treatment Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Type-1 Diabetes Treatment Revenue Market Share by Player (2020-2025)
Table 14. Type-1 Diabetes Treatment Key Players Head office and Products Offered
Table 15. Type-1 Diabetes Treatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Type-1 Diabetes Treatment Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Type-1 Diabetes Treatment Market Size Market Share by Region (2020-2025)
Table 20. Global Type-1 Diabetes Treatment Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Type-1 Diabetes Treatment Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Type-1 Diabetes Treatment Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Type-1 Diabetes Treatment Market Size Market Share by Country (2020-2025)
Table 24. Americas Type-1 Diabetes Treatment Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Type-1 Diabetes Treatment Market Size Market Share by Type (2020-2025)
Table 26. Americas Type-1 Diabetes Treatment Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Type-1 Diabetes Treatment Market Size Market Share by Application (2020-2025)
Table 28. APAC Type-1 Diabetes Treatment Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Type-1 Diabetes Treatment Market Size Market Share by Region (2020-2025)
Table 30. APAC Type-1 Diabetes Treatment Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Type-1 Diabetes Treatment Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Type-1 Diabetes Treatment Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Type-1 Diabetes Treatment Market Size Market Share by Country (2020-2025)
Table 34. Europe Type-1 Diabetes Treatment Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Type-1 Diabetes Treatment Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Type-1 Diabetes Treatment Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Type-1 Diabetes Treatment Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Type-1 Diabetes Treatment Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Type-1 Diabetes Treatment
Table 40. Key Market Challenges & Risks of Type-1 Diabetes Treatment
Table 41. Key Industry Trends of Type-1 Diabetes Treatment
Table 42. Global Type-1 Diabetes Treatment Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Type-1 Diabetes Treatment Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Type-1 Diabetes Treatment Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Type-1 Diabetes Treatment Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Astellas Pharma Details, Company Type, Type-1 Diabetes Treatment Area Served and Its Competitors
Table 47. Astellas Pharma Type-1 Diabetes Treatment Product Offered
Table 48. Astellas Pharma Type-1 Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Astellas Pharma Main Business
Table 50. Astellas Pharma Latest Developments
Table 51. Merck Details, Company Type, Type-1 Diabetes Treatment Area Served and Its Competitors
Table 52. Merck Type-1 Diabetes Treatment Product Offered
Table 53. Merck Type-1 Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Merck Main Business
Table 55. Merck Latest Developments
Table 56. Eli Lilly Details, Company Type, Type-1 Diabetes Treatment Area Served and Its Competitors
Table 57. Eli Lilly Type-1 Diabetes Treatment Product Offered
Table 58. Eli Lilly Type-1 Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Eli Lilly Main Business
Table 60. Eli Lilly Latest Developments
Table 61. Novo Nordisk Details, Company Type, Type-1 Diabetes Treatment Area Served and Its Competitors
Table 62. Novo Nordisk Type-1 Diabetes Treatment Product Offered
Table 63. Novo Nordisk Type-1 Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Novo Nordisk Main Business
Table 65. Novo Nordisk Latest Developments
Table 66. Sanofi Details, Company Type, Type-1 Diabetes Treatment Area Served and Its Competitors
Table 67. Sanofi Type-1 Diabetes Treatment Product Offered
Table 68. Sanofi Type-1 Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Sanofi Main Business
Table 70. Sanofi Latest Developments
Table 71. AstraZeneca Details, Company Type, Type-1 Diabetes Treatment Area Served and Its Competitors
Table 72. AstraZeneca Type-1 Diabetes Treatment Product Offered
Table 73. AstraZeneca Type-1 Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. AstraZeneca Main Business
Table 75. AstraZeneca Latest Developments
Table 76. Boehringer Ingelheim GmbH Details, Company Type, Type-1 Diabetes Treatment Area Served and Its Competitors
Table 77. Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Product Offered
Table 78. Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Boehringer Ingelheim GmbH Main Business
Table 80. Boehringer Ingelheim GmbH Latest Developments
Table 81. Novartis Details, Company Type, Type-1 Diabetes Treatment Area Served and Its Competitors
Table 82. Novartis Type-1 Diabetes Treatment Product Offered
Table 83. Novartis Type-1 Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Novartis Main Business
Table 85. Novartis Latest Developments
Table 86. Pfizer Inc. Details, Company Type, Type-1 Diabetes Treatment Area Served and Its Competitors
Table 87. Pfizer Inc. Type-1 Diabetes Treatment Product Offered
Table 88. Pfizer Inc. Type-1 Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Pfizer Inc. Main Business
Table 90. Pfizer Inc. Latest Developments
Table 91. Abbott Laboratories Details, Company Type, Type-1 Diabetes Treatment Area Served and Its Competitors
Table 92. Abbott Laboratories Type-1 Diabetes Treatment Product Offered
Table 93. Abbott Laboratories Type-1 Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Abbott Laboratories Main Business
Table 95. Abbott Laboratories Latest Developments
Table 96. Mannkind Corporation Details, Company Type, Type-1 Diabetes Treatment Area Served and Its Competitors
Table 97. Mannkind Corporation Type-1 Diabetes Treatment Product Offered
Table 98. Mannkind Corporation Type-1 Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Mannkind Corporation Main Business
Table 100. Mannkind Corporation Latest Developments
Table 101. Braun Melsungen AG Details, Company Type, Type-1 Diabetes Treatment Area Served and Its Competitors
Table 102. Braun Melsungen AG Type-1 Diabetes Treatment Product Offered
Table 103. Braun Melsungen AG Type-1 Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. Braun Melsungen AG Main Business
Table 105. Braun Melsungen AG Latest Developments
Table 106. Macrogenics, Inc. Details, Company Type, Type-1 Diabetes Treatment Area Served and Its Competitors
Table 107. Macrogenics, Inc. Type-1 Diabetes Treatment Product Offered
Table 108. Macrogenics, Inc. Type-1 Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 109. Macrogenics, Inc. Main Business
Table 110. Macrogenics, Inc. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Type-1 Diabetes Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Type-1 Diabetes Treatment Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Type-1 Diabetes Treatment Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Type-1 Diabetes Treatment Sales Market Share by Country/Region (2024)
Figure 8. Type-1 Diabetes Treatment Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Type-1 Diabetes Treatment Market Size Market Share by Type in 2024
Figure 10. Type-1 Diabetes Treatment in Hospitals & Clinics
Figure 11. Global Type-1 Diabetes Treatment Market: Hospitals & Clinics (2020-2025) & ($ millions)
Figure 12. Type-1 Diabetes Treatment in Academic & Research Institutes
Figure 13. Global Type-1 Diabetes Treatment Market: Academic & Research Institutes (2020-2025) & ($ millions)
Figure 14. Global Type-1 Diabetes Treatment Market Size Market Share by Application in 2024
Figure 15. Global Type-1 Diabetes Treatment Revenue Market Share by Player in 2024
Figure 16. Global Type-1 Diabetes Treatment Market Size Market Share by Region (2020-2025)
Figure 17. Americas Type-1 Diabetes Treatment Market Size 2020-2025 ($ millions)
Figure 18. APAC Type-1 Diabetes Treatment Market Size 2020-2025 ($ millions)
Figure 19. Europe Type-1 Diabetes Treatment Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Type-1 Diabetes Treatment Market Size 2020-2025 ($ millions)
Figure 21. Americas Type-1 Diabetes Treatment Value Market Share by Country in 2024
Figure 22. United States Type-1 Diabetes Treatment Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Type-1 Diabetes Treatment Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Type-1 Diabetes Treatment Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Type-1 Diabetes Treatment Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Type-1 Diabetes Treatment Market Size Market Share by Region in 2024
Figure 27. APAC Type-1 Diabetes Treatment Market Size Market Share by Type (2020-2025)
Figure 28. APAC Type-1 Diabetes Treatment Market Size Market Share by Application (2020-2025)
Figure 29. China Type-1 Diabetes Treatment Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Type-1 Diabetes Treatment Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Type-1 Diabetes Treatment Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Type-1 Diabetes Treatment Market Size Growth 2020-2025 ($ millions)
Figure 33. India Type-1 Diabetes Treatment Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Type-1 Diabetes Treatment Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Type-1 Diabetes Treatment Market Size Market Share by Country in 2024
Figure 36. Europe Type-1 Diabetes Treatment Market Size Market Share by Type (2020-2025)
Figure 37. Europe Type-1 Diabetes Treatment Market Size Market Share by Application (2020-2025)
Figure 38. Germany Type-1 Diabetes Treatment Market Size Growth 2020-2025 ($ millions)
Figure 39. France Type-1 Diabetes Treatment Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Type-1 Diabetes Treatment Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Type-1 Diabetes Treatment Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Type-1 Diabetes Treatment Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Type-1 Diabetes Treatment Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Type-1 Diabetes Treatment Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Type-1 Diabetes Treatment Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Type-1 Diabetes Treatment Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Type-1 Diabetes Treatment Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Type-1 Diabetes Treatment Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Type-1 Diabetes Treatment Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Type-1 Diabetes Treatment Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Type-1 Diabetes Treatment Market Size 2026-2031 ($ millions)
Figure 52. APAC Type-1 Diabetes Treatment Market Size 2026-2031 ($ millions)
Figure 53. Europe Type-1 Diabetes Treatment Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Type-1 Diabetes Treatment Market Size 2026-2031 ($ millions)
Figure 55. United States Type-1 Diabetes Treatment Market Size 2026-2031 ($ millions)
Figure 56. Canada Type-1 Diabetes Treatment Market Size 2026-2031 ($ millions)
Figure 57. Mexico Type-1 Diabetes Treatment Market Size 2026-2031 ($ millions)
Figure 58. Brazil Type-1 Diabetes Treatment Market Size 2026-2031 ($ millions)
Figure 59. China Type-1 Diabetes Treatment Market Size 2026-2031 ($ millions)
Figure 60. Japan Type-1 Diabetes Treatment Market Size 2026-2031 ($ millions)
Figure 61. Korea Type-1 Diabetes Treatment Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Type-1 Diabetes Treatment Market Size 2026-2031 ($ millions)
Figure 63. India Type-1 Diabetes Treatment Market Size 2026-2031 ($ millions)
Figure 64. Australia Type-1 Diabetes Treatment Market Size 2026-2031 ($ millions)
Figure 65. Germany Type-1 Diabetes Treatment Market Size 2026-2031 ($ millions)
Figure 66. France Type-1 Diabetes Treatment Market Size 2026-2031 ($ millions)
Figure 67. UK Type-1 Diabetes Treatment Market Size 2026-2031 ($ millions)
Figure 68. Italy Type-1 Diabetes Treatment Market Size 2026-2031 ($ millions)
Figure 69. Russia Type-1 Diabetes Treatment Market Size 2026-2031 ($ millions)
Figure 70. Egypt Type-1 Diabetes Treatment Market Size 2026-2031 ($ millions)
Figure 71. South Africa Type-1 Diabetes Treatment Market Size 2026-2031 ($ millions)
Figure 72. Israel Type-1 Diabetes Treatment Market Size 2026-2031 ($ millions)
Figure 73. Turkey Type-1 Diabetes Treatment Market Size 2026-2031 ($ millions)
Figure 74. Global Type-1 Diabetes Treatment Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Type-1 Diabetes Treatment Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Type-1 Diabetes Treatment Market Size 2026-2031 ($ millions)